A case of corneal opacity caused by atovaquone administration

Purpose: Atovaquone is an alternative drug that is used for the prevention and treatment of Pneumocystis pneumonia when the first-line drug, sulfamethoxazole-trimethoprim (ST combination), cannot be used due to side effects. However, atovaquone is known to cause ocular side effects including oculomu...

Full description

Bibliographic Details

Published in:	American Journal of Ophthalmology Case Reports
Main Authors:	Takeyoshi Ashizuka, Masafumi Uematsu, Mohamed Talaat Mohamed, Mao Kusano, Mohamed Yasser Helmy, Daisuke Inoue, Takashi Kitaoka
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Subjects:	Atovaquone Corneal opacity
Online Access:	http://www.sciencedirect.com/science/article/pii/S2451993624002457